Clin2
NCT07582926Possibly a fitRecruiting

Cortisol Levels and Outcomes in Critically Ill Infection Patients

SepsisSeptic Shock

Part of Infections clinical trials.

This study examines how the body's stress hormone (cortisol) relates to survival in patients with severe blood infections in the ICU. Understanding this relationship may help doctors better predict and manage outcomes in critically ill patients.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
183 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years old or older
  • You have been admitted to an intensive care unit (ICU) and stayed there for more than 24 hours
  • You have a confirmed infection (diagnosed by clinical signs or laboratory tests)
  • You have been diagnosed with sepsis or septic shock (severe infection affecting your whole body) during your ICU stay
  • You are not pregnant
  • You do not have a known condition affecting your pituitary gland or adrenal glands (which control cortisol production)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06289179Not yet recruiting
Thyroid and cortisol hormone response to sepsis

This study looks at how thyroid and cortisol hormones change in adults with sepsis (a serious infection) in the ICU. It may help understand how the body reacts during critical illness.

NCT07245550Not yet recruiting
Thyroid and adrenal health in ICU patients

This study looks at how often thyroid and adrenal problems occur in people with sepsis or septic shock in the ICU. It may help doctors understand if these hormone issues happen more often during critical illness.

Asyut
NCT04280497Recruiting
Testing fast ways to tell steroid-resistant sepsis from sensitive

This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.

Garches, Hauts-de-Seine
NCT07682766Recruiting
Biomarkers of inflammation and infection in critical care

This study looks at markers of inflammation, infection, and immunity in patients who are in the critical care area. It aims to find early signs of how severe the illness might become, how well treatments work, and if infections will develop.

Torino
NCT07770347Enrolling by invitation
Sepsis and the immune system study

This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.

Beijing, Beijing Municipality
NCT07453901Not yet recruiting
Study on how septic shock is managed in ICUs

This study observes how doctors treat septic shock in intensive care units. It aims to understand current practices and improve care for patients with severe infections and low blood pressure.

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.